Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE) has announced that its board of directors will meet on Tuesday, August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, on both a standalone and consolidated basis. The company will also host an earnings and analyst conference call on the same day at 5:30 PM IST to discuss the results with investors and analysts.
Key Highlights
- The board meeting is scheduled for Tuesday, August 4, 2026, to approve unaudited financial results for Q1 FY27 (quarter ended June 30, 2026) on standalone and consolidated bases.
- An earnings and analyst conference call will be held on August 4, 2026, from 5:30 PM to 6:30 PM IST to discuss the quarterly financial results with investors and analysts.
- The company's trading window will remain closed until 48 hours after the announcement of the financial results in compliance with the Code of Conduct for Prevention of Insider Trading.
- Dr. Adil Agarwal (Whole-time Director and CEO), Mr. Yashwanth Venkat (CFO), and Ms. Aashna Dharia (Head of Investor Relations) will represent the company on the conference call.
- Multiple dial-in numbers and an express join link via Diamond Pass registration have been provided for both Indian and international participants on the conference call.
About the Company
Dr. Agarwal's Health Care Limited is a healthcare services provider headquartered in Chennai and listed on both the BSE (Scrip Code: 544350) and NSE (Symbol: AGARWALEYE). The company operates in the healthcare sector, offering comprehensive eye care and related medical services. The organisation is represented by experienced management including Dr. Adil Agarwal as Whole-time Director and Chief Executive Officer, supported by a finance team led by Chief Financial Officer Mr. Yashwanth Venkat. The company maintains investor relations through a dedicated investor relations team and communicates with stakeholders through periodic board meetings and analyst conferences.
Announcement in Detail
Dr. Agarwal's Health Care Limited has intimated the stock exchanges of an upcoming board meeting scheduled for Tuesday, August 4, 2026. The primary agenda of this meeting is to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2026. The results will be presented on both a standalone and consolidated basis, providing shareholders and investors with a comprehensive view of the company's financial performance during the first quarter of fiscal year 2027.
In accordance with the company's Code of Conduct for Prevention of Insider Trading, the trading window for employees and designated persons will remain closed until 48 hours after the formal announcement of the financial results. This closure is implemented to prevent the trading of securities by insiders during periods when they may have access to material non-public information, ensuring compliance with SEBI's insider trading regulations.
Alongside the board meeting, Dr. Agarwal's Health Care Limited will host an earnings and analyst conference call on the same day, August 4, 2026, scheduled from 5:30 PM to 6:30 PM IST. This conference call will provide an opportunity for investors, analysts, and other market participants to discuss the quarterly financial results directly with company management. The company's executive team, comprising Dr. Adil Agarwal (Whole-time Director and CEO), Mr. Yashwanth Venkat (CFO), and Ms. Aashna Dharia (Head of Investor Relations), will participate in the call to address questions and provide insights into the company's operational and financial performance.
Impact on Investors
Investors will note that the board meeting on August 4, 2026, represents a key event in the company's quarterly disclosure calendar. The approval and announcement of Q1 FY27 unaudited financial results will provide material information necessary for investors to assess the company's financial health, operational performance, and key metrics including revenue, profitability, margins, and other relevant financial indicators. The filing indicates that both standalone and consolidated results will be disclosed, allowing investors to evaluate the company's performance on both bases and understand the contribution of any subsidiaries or associate entities to overall performance.
The investor impact from this announcement is primarily procedural and informational. The conference call on the same day offers investors and analysts direct access to company management to seek clarification on results, discuss business developments, and raise questions about future outlook and strategy. Investors should note that the trading window closure until 48 hours after results announcement is a regulatory requirement designed to protect market integrity and prevent information asymmetry. The announcement itself does not indicate any changes to dividend policy, capital structure, or strategic direction, but these matters may be addressed during the earnings call or in separate communications by the company.
Sector / Market Context
Dr. Agarwal's Health Care Limited operates in the Indian healthcare services sector, a segment that has witnessed steady growth driven by increasing demand for quality medical services, rising healthcare awareness, and expansion of healthcare infrastructure across urban and semi-urban regions. The eye care segment, in particular, remains a significant component of the broader healthcare market in India. Quarterly board meetings and results announcements form part of standard corporate governance practice under the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, requiring listed companies to maintain transparency and regular communication with shareholders. The conduct of analyst conference calls has become a standard practice among listed healthcare companies to facilitate market understanding of quarterly performance metrics and company strategy.